Male inbred Lewis rats were injected as previously describedl 4 with 0,25 mg bovine P2 or 2 5 mg bovine
Experimental allergic neuritis (EAN) produced by immunisation with an emulsion of peripheral nerve and adjuvant is an important model of human acute inflammatory polyneuropathy (Guillain-Barre-Strohl syndrome) which it closely resembles histologically. Study of its immunological mechanisms was delayed because in most species the disease was contaminated by inflammation of the central nervous system, that is experimental allergic encephalomyelitis (EAE), and the identity of the neuritogenic antigen was not known. It has recently been shown that bovine peripheral nerve myelin injected into inbred Lewis rats produces pure EAN without EAE,1 2 3 and that P2 basic protein purified from that myelin is responsible for the neuritogenic activity.' 4 5 This paper describes the humoral and cellular responses to P2 during EAN and the passive transfer of the disease with lymph node cells.
Methods
Male inbred Lewis rats were injected as previously describedl 4 with 0,25 mg bovine P2 or 2 5 mg bovine peripheral nerve myelin, emulsified with adjuvant containing 0'5 mg Mycobacterium tuberculosis, and killed after days. The severity of neurological signs was graded 0=normal, + =limp tail, + +=para-paresis, +++=paraplegia, tetraparesis or death. The mean scores in table 1 refer to the signs of 4-6 rats at the time of sacrifice when blood and lymph nodes were collected. The scores correspond closely to those obtained in previous experiments with 10 rats immunised with the same dose of P2 and 10 with the same dose of myelin. Histological examination was In 21 complete adjuvant immunised control rats injection of P2 produced no erythema or induration (mean depth of induration ±SD=0-00±0(04 mm). In the P2 and myelin immunised animals P2 produced positive skin tests 7-10 days after immunisation (table 2). The induration was less than with similar tests with PPD (table 3) and erythema, although present, was difficult to measure accurately. In the P2 immunised rats the positive skin tests persisted during the disease whereas in the myelin immunised rats the skin reaction to P2 and PPD diminished (tables 2 and 3).
In the lymph node cell transformation tests, addition of P2 100 ,ug/jd produced an increment in 3H-thymidine incorporation of lymph node cells from all the groups of rats. Only the cells from the rats immunised with pure P2 had a significantly Table 2 Skin tests with 50 ,ug P2 in P2 and myelin immunised rats 10 The myelin splitting preceding cellular infiltration and prominent Schwann cell death in the galactocerebroside induced lesion are not described in EAN induced by whole nerve or myelin" nor have we noted them in our own material. Hoffman et al3 were unable to produce disease in rats with galactocerebroside so that species differences are probably important.
The time course of skin test responses to P2 did not correspond to the development and disappearance of neurological signs any more closely than the antibody levels (table 2). In the P2 immunised rats the skin test became positive after 10 days just before the onset of neurological signs and remained positive for the next three weeks. In the myelin immunised rats a positive skin test reaction with P2 appeared at 7-12 days but then disappeared despite the fact that these animals had disease which was at least as severe as those immunised with P2. The skin test reaction with PPD was depressed in the P2 immunised rats after 21 days and the myelin immunised rats after 14 days compared with the adjuvant immunised controls. It is possible that the disappearance of the positive skin test to P2 in the myelin immunised animals and depression of PPD response in both groups represents a non-specific response to stress. Another possible mechanism would be that the available sensitised cells have left the circulation having been attracted by the target antigen in the peripheral nerve or adjuvant depots. An 
